Mass spectrometric characterization of glucuronides formed by a new concept, combining Cunninghamella elegans with TEMPO

Journal of Pharmaceutical and Biomedical Analysis

Volumn 84, Issue , 2013, Pages 278-284

  Rydevik, Axel ^a   Bondesson, Ulf ^a,b   Thevis, Mario ^c   Hedeland, Mikael ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b NATIONAL VETERINARY INSTITUTE   (Sweden)

^c GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

Glucuronides; High resolution mass spectrometry; SARM; TEMPO; UPLC

Indexed keywords

BETA GLUCURONIDASE; FREE RADICAL; GLUCOSIDE; GLUCURONIC ACID; GLUCURONIDE; SELECTIVE ANDROGEN RECEPTOR MODULATOR; TETRAMETHYLPIPERIDINYL 1 OXY; UNCLASSIFIED DRUG;

ARTICLE; COMPARATIVE STUDY; CUNNINGHAMELLA ELEGANS; DRUG CONJUGATION; GLUCURONIDATION; HUMAN; HUMAN CELL; LIVER MICROSOME; NONHUMAN; OXIDATION; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; SOLID PHASE EXTRACTION; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

GLUCURONIDES; HIGH RESOLUTION MASS SPECTROMETRY; HRMS; NADPH; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SARM; SELECTIVE ANDROGEN RECEPTOR MODULATOR; TEMPO; TETRAMETHYLPIPERIDINYL-1-OXY; UDPGA; UPLC; URIDINE 5′-DIPHOSPHOGLUCURONIC ACID;

AMIDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CUNNINGHAMELLA; CYCLIC N-OXIDES; GLUCOSIDES; GLUCURONIC ACID; GLUCURONIDES; HUMANS; IONS; MASS SPECTROMETRY; METABOLIC DETOXICATION, PHASE II; MICROSOMES, LIVER;

EID: 84880646564     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2013.06.012     Document Type: Article

References (23)

1. Levsen K., Schiebel H.-M., Behnke B., Dötzer R., Dreher W., Elend M., et al. Structure elucidation of phase II metabolites by tandem mass spectrometry: an overview. J. Chromatogr. A 2005, 1067:55-72.
2. Ionescu C., Caira M. Pathways of biotransformation - phase II reactions. Drug Metabolism 2005, 129-170. Springer, Netherlands. C. Ionescu, M. Caira (Eds.).
3. Stachulski A.V., Jenkins G.N. The synthesis of O-glucuronides. Nat. Prod. Rep. 1998, 15:173-186.
4. Kuuranne T., Leinonen A., Schanzer W., Kamber M., Kostiainen R., Thevis M. Aryl-propionamide-derived selective androgen receptor modulators: liquid chromatography-tandem mass spectrometry characterization of the in vitro synthesized metabolites for doping control purposes. Drug Metab. Dispos. 2008, 36:571-581.
5. Krug O., Thomas A., Beuck S., Schenk I., Machnik M., Schänzer W., et al. Characterization of in vitro synthesized equine metabolites of the selective androgen receptor modulators S24 and S4. J. Equine Vet. Sci. 2012, 32:562-568.
6. Lundahl A., Lennernaes H., Knutson L., Bondesson U., Hedeland M. Identification of finasteride metabolites in human bile and urine by high-performance liquid chromatography/tandem mass spectrometry. Drug Metab. Dispos. 2009, 37:2008-2017.
7. Buchheit D., Schmitt E.I., Bischoff D., Ebner T., Bureik M. S-glucuronidation of 7-mercapto-4-methylcoumarin by human UDP glycosyltransferases in genetically engineered fission yeast cells. Biol. Chem. 2011, 392:1089-1095.
8. Drǎgan C.-A., Buchheit D., Bischoff D., Ebner T., Bureik M. Glucuronide production by whole-cell biotransformation using genetically engineered fission yeast Schizosaccharomyces pombe. Drug Metab. Dispos. 2010, 38:509-515.
9. Huang H.H., Lin L.H., Zhang P., Qi X.L., Zhong D.F. Formation of glucoside conjugate of acetaminophen by fungi separated from soil. Eur. J. Drug Metabol. Pharmacokinet. 2006, 31:103-108.
10. Melvin F., McNeill A., Henderson P.J.F., Herbert R.B. The improved synthesis of β-d-glucuronides using TEMPO and t-butyl hypochlorite. Tetrahedron Lett. 1999, 40:1201-1202.
11. Bouktaib M., Atmani A., Rolando C. Regio- and stereoselective synthesis of the major metabolite of quercetin, quercetin-3-O-β-d-glucuronide. Tetrahedron Lett. 2002, 43:6263-6266.
12. Ma B., Huang H., Chen X., Sun Y., Lin L., Zhong D. Biotransformation of metoprolol by the fungus Cunninghamella blakesleeana. Acta Pharmacol. Sin. 2007, 28:1067-1074.
13. Moody J.D., Freeman J.P., Cerniglia C.E. Biotransformation of doxepin by Cunninghamella elegans. Drug Metab. Dispos. 1999, 27:1157-1164.
14. Pearce C.M., Lushnikova M.V. Microbiological production of omeprazole metabolites by Cunninghamella elegans. J. Mol. Catal. B: Enzym. 2006, 41:87-91.
15. Rydevik A., Bondesson U., Hedeland M. Structural elucidation of phase I and II metabolites of bupivacaine in horse urine and fungi of the Cunninghamella species using liquid chromatography/multi-stage mass spectrometry. Rapid Commun. Mass Spectrom. 2012, 26:1338-1346.
16. Rydevik A., Thevis M., Krug O., Bondesson U., Hedeland M. The fungus Cunninghamella elegans can produce human and equine metabolites of selective androgen receptor modulators (SARMs). Xenobiotica 2012, 43:409-420.
17. Asha S., Vidyavathi M. Cunninghamella - a microbial model for drug metabolism studies - a review. Biotechnol. Adv. 2009, 27:16-29.
18. Cerniglia C.E., Miller D.W., Yang S.K., Freeman J.P. Effects of a fluoro substituent on the fungal metabolism of 1-fluoronaphthalene. Appl. Environ. Microbiol. 1984, 48:294-300.
19. Cerniglia C.E., Freeman J.P., Mitchum R.K. Glucuronide and sulfate conjugation in the fungal metabolism of aromatic hydrocarbons. Appl. Environ. Microbiol. 1982, 43:1070-1075.
20. Thevis M., Thomas A., Möller I., Geyer H., Dalton J.T., Schänzer W. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls. Rapid Commun. Mass Spectrom. 2011, 25:2187-2195.
21. Metabolites of selective androgen receptor modulators and methods of use thereof, U.S. Patent WO 2009/155481 A1 (2009).
22. Thevis M., Kamber M., Schanzer W. Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes. Rapid Commun. Mass Spectrom. 2006, 20:870-876.
23. Zhang D., Yang Y., Leakey J.E.A., Cerniglia C.E. Phase I and phase II enzymes produced by Cunninghamella elegans for the metabolism of xenobiotics. FEMS Microbiol. Lett. 1996, 138:221-226.